Transaktionen anzeigen
Healthcare | Private Equity

Saneca Pharmaceuticals, a.s. has acquired Suir Pharma Ireland

Saneca Pharmaceuticals, a.s. (Saneca) has acquired Suir Pharma Ireland from mutares AG, an industrial holding company. Financial details have not been disclosed.

Saneca is a pharmaceutical contract manufacturing company active in the development, production, registration and distribution of generic medicines and active pharmaceutical ingredients. Saneca also owns a portfolio of cosmetic and generic products.

Suir Pharma Ireland is an independent contract manufacturing company working with many established pharmaceutical companies worldwide. Formerly a Stada AG manufacturing site, Suir Pharma Ireland is well known as an established manufacturer of generic medicines for more than 40 years with the highest quality standards. The company supplies various markets in Europe and the USA.

mutares AG is an industrial holding company that focuses on the acquisition of companies currently finding themselves in a special situation, such as owner or management succession, strategic repositioning and re-funding.

Oaklins' team in Slovakia advised the buyer in this transaction.

Art der transaktion
BETEILIGTE PARTEIEN

Sprechen Sie mit dem Deal-Team

Vladimír Jaros

Principal
Prag, Tschechien
Oaklins WOOD & Co.

Transaktionen

Sun European Partners has secured financing to support its acquisition of B&H Worldwide
Private Equity | Logistics

Sun European Partners has secured financing to support its acquisition of B&H Worldwide

Sun European Partners has raised debt facilities to support its acquisition of B&H Worldwide.

Mehr erfahren
Ebidco has finalized a voluntary public tender offer for the shares of Eles Semiconductor Equipment
Private Equity | Industrial Machinery & Components

Ebidco has finalized a voluntary public tender offer for the shares of Eles Semiconductor Equipment

Ebidco S.r.l. has completed a voluntary public tender offer for the shares of Eles Semiconductor Equipment S.p.A.

Mehr erfahren
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Mehr erfahren